As the FDA removes semaglutide and tirzepatide from its drug shortage list, compounders will likely be required to halt production
Crohns Colitis 17 , 777785 (2023)
Always consult your doctor or healthcare provider for personalized guidance regarding your health
HCG injections: Once popular but now controversial
"We made a deliberate strategic pivot within our weight loss specialty, one that we knew would create near-term financial noise to unlock immense potential for the platform to accelerate at scale," Yemi Okupe, chief financial officer at Hims & Hers, told investors during the company's Q1 earnings call on Monday
Plus, says Barrient, the shots may be covered by insurance if your doctor can show that you can really benefit from them